The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Despite the huge human and economic toll, research into hepatitis B remains drastically underfunded, and was recently alikened to a neglected tropical disease. But hope for a cure is growing.
Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.
First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.
Progress in halting TB – the world’s leading infectious disease killer – is plagued by a lack of political will and inequalities in healthcare access
Cryptococcal meningitis (crypto) may not be the first thing that comes to mind when talking about HIV – but this common opportunistic infection and AIDS-defining illness is one of the leading killers of people living with HIV globally.
Doctors at Georgetown University in the USA have reported the first diagnosed case of Alzheimer’s disease in a person living with HIV. It was previously thought that HIV-related inflammation in the brain may prevent amyloid deposition – one of the likely causes of Alzheimer’s disease.
For the first time ever, more people have died from tuberculosis (TB) than from HIV, making TB the biggest infectious disease killer globally.
This World Tuberculosis (TB) Day, UNAIDS have called for a greater integration of HIV and TB services in order to combat the dual epidemics. In 2013, over 9 million people were diagnosed with TB, of which 1.1 million were also living with HIV. PLHIV are around 30 times more likely to develop opportunistic infections such as TB, with TB being the leading cause of death for PLHIV – among this group, 360,000 deaths can be attributed to TB alone.
The large majority of cases of extensively drug-resistant tuberculosis (XDR-TB) in Kwa-Zulu Natal, South Africa, were acquired via person-to-person, and not as a result of treatment failure, as originally believed. These results were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle this week, and demonstrate the need to focus attention on infection control and prevention in the region.
Tuberculosis (TB) remains one of the world’s deadliest communicable diseases states the latest Global Tuberculosis Report by the World Health Organization. In 2013, an estimated 9 million people were infected with TB with 1.5 million dying from the disease. Of which, 360 000 people were co-infected with TB and HIV.